Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.22.2
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue $ 6,261 $ 0 $ 14,086 $ 10,000
Operating expense:        
Cost of revenues 17,140 0 51,363 10,102
Selling, general and administrative expense 836,215 1,370,395 3,308,227 3,600,419
Research and development expense 159,846 297,553 922,120 1,051,755
Total costs and expenses 1,013,200 1,667,948 4,281,710 4,662,276
Loss from operations (1,006,940) (1,667,948) (4,267,624) (4,652,276)
Other income (expense):        
Interest expense (39,890) (40,186) (119,671) (110,202)
Gain on forgiveness of loan 0 178,229 (0) 178,229
Decrease to fair value of derivative liability 0 0 1,000,000 108,944
Total other income (expense) (39,890) 138,043 880,329 176,971
Net loss $ (1,046,830) $ (1,529,905) $ (3,387,295) $ (4,475,305)
Loss per share - basic and diluted        
Net loss per common share - basic and diluted (in dollars per share) $ 0.00 $ (0.01) $ (0.01) $ (0.02)
Weighted common shares - basic and diluted (in shares) 236,947,517 236,719,770 236,853,195 214,289,567